slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 32,611-32,640
Pages 1,379
Rows per page 30
Component
32,611-32,640 of 41,369
38
The slide uses a bar chart to illustrate additive clinical remission rates, with a table below providing additional clinical metrics (N, maintenance remission, safety).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
40
Includes a specific note that this is an 'Illustrative example' and 'Preliminary; pending regulatory feedback'.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
43
The slide uses a comparative bar chart structure to show the delta in efficacy when using a companion diagnostic (CDx).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
46
The slide uses a table-based timeline format to track R&D progress and external data readouts.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
47
The table uses a custom visualization for market cap range (min, IPO, today, max) and clinical stage progression.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
48
The table maps historical industry M&A deals to Spyre's internal pipeline development milestones (2025-2027).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
04
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
08
The slide uses a three-column layout to present strategic priorities, with a footer highlighting stock performance relative to peers.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
13
The slide highlights a 50% improvement in valuation multiple despite a decline in the NBI index multiple.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
16
The slide uses a dual-axis timeline (top and bottom) to annotate events on a stock price chart.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & Proof1 hit
17
The table categorizes products into 'Proprietary' and 'Royalty' streams.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
19
The slide uses a bar chart to show quarterly net sales growth from Q4'21 to Q1'23.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
20
The slide uses donut charts to represent revenue composition and growth.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
24
The slide uses a chronological sequence to demonstrate management's effective handling of a major revenue threat.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
25
The slide uses a hub-and-spoke diagram to show the core Alkermes business and a separate branch for the oncology spin-off.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
29
The slide uses a table-like structure to compare four board members.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
31
Includes a specific quote from an ISS recommendation regarding majority voting standards.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
32
Uses a before-after framing to show how shareholder feedback led to specific governance improvements.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
35
This slide is part of a proxy contest defense, specifically attacking the credibility and suitability of the activist's nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
36
The slide uses a two-column layout to contrast the 'Process' of board composition with the 'Decision Making' regarding specific nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
37
The slide uses a red-themed table to highlight negative attributes of specific individuals.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
39
The slide uses a checkmark matrix to demonstrate board competency across five key areas: Neuroscience, Financial/Transactional, Commercial, Medical/R&D, and Global Business.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
40
This is a proxy fight slide comparing incumbent board members against challenger nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
41
The slide uses a sidebar callout to emphasize the Board's role in initiating the transformation.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
50
The slide uses a list of governance attributes on the left and three donut charts on the right to illustrate compensation design.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
04
The slide uses a circular graphic element to emphasize the 'revolution' in autoimmunity.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Why1 hit
11
The slide uses a geographic split between US and Global markets to track approval timelines.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a hub-and-spoke visual metaphor to link the clinical class to the specific biological targets.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
13
The slide uses a pyramid structure to represent market size, with smaller patient populations at the top and larger ones at the bottom.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
14
The slide uses a visual representation of an antibody to explain its 'sweeping' mechanism.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit